A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancer

Recurrent clear cell ovarian carcinoma is a difficult to treat condition and early trial data has suggested a possible role for immune checkpoint inhibitors. Nivolumab is an anti-PD-1 immunotherapy that has been used in this setting. While immune related toxicity of these agents has been well descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Morgan, Hardesty, Melissa, Downs, Wayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003404/
https://www.ncbi.nlm.nih.gov/pubmed/29915799
http://dx.doi.org/10.1016/j.gore.2018.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003404/
https://www.ncbi.nlm.nih.gov/pubmed/29915799
http://dx.doi.org/10.1016/j.gore.2018.03.007

Ejemplares similares